KELLY KRAUSE: Open Payments
NPI 1487063897 · MOUNTAIN HOME, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 20 payments from 10 companies in 2025. Trend: 2023 $243 · 2024 $342 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $68 |
| Amgen Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $60 |
| ABBVIE INC. | 3 | $59 |
| UCB, Inc. | 2 | $55 |
| Janssen Biotech, Inc. | 2 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
| LEO Pharma Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: DUPIXENT, OTEZLA, TALTZ, SKYRIZI, Bimzelx, TREMFYA, ILUMYA, ADBRY.
Industry payments across AR — which companies pay providers there.
